Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Non Operating Income: 2017-2023

Historic Other Non Operating Income for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2023 value amounting to -$577,659.

  • Outlook Therapeutics' Other Non Operating Income rose 1554.92% to $6.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was -$3.6 million, marking a year-over-year change of. This contributed to the annual value of -$577,659 for FY2023, which is 43.67% up from last year.
  • According to the latest figures from FY2023, Outlook Therapeutics' Other Non Operating Income is -$577,659, which was up 43.67% from -$1.0 million recorded in FY2022.
  • Over the past 5 years, Outlook Therapeutics' Other Non Operating Income peaked at -$577,659 during FY2023, and registered a low of -$1.9 million during FY2020.
  • Moreover, its 2-year median value for Other Non Operating Income was -$801,530 (2022), whereas its average is -$801,530.
  • In the last 5 years, Outlook Therapeutics' Other Non Operating Income surged by 51.51% in 2019 and then slumped by 212.28% in 2020.
  • Outlook Therapeutics' Other Non Operating Income (Yearly) stood at -$607,240 in 2019, then crashed by 212.28% to -$1.9 million in 2020, then reached -$1.0 million in 2022, then surged by 43.67% to -$577,659 in 2023.